πŸ‡ΊπŸ‡Έ FDA
Patent

US 10307423

FBXO3 inhibitors

granted A61KA61K31/137A61K31/341

Quick answer

US patent 10307423 (FBXO3 inhibitors) held by United States Government as represented by the Department of Veterans Affairs expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K31/137, A61K31/341, A61K31/381, A61K31/402